Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stonyfield, Steaz Foray Into Energy Drink Market With Healthy Alternatives

This article was originally published in The Tan Sheet

Executive Summary

Stonyfield Farm and Steaz Soda aim to bring healthy alternatives to the energy drink market with the launch of beverages that offer organic ingredients

You may also be interested in...



NMI data

"More than half of all consumers are seeking food and supplements that help them prevent energy loss," Steven French, managing partner at the Natural Marketing Institute said Aug. 7. According to NMI's Health & Wellness Trends Database, issues related to energy and vitality are of concern to 75% of consumers. All age groups from Gen Y to Boomers are worried about either specific fatigue issues or stamina "to fulfill their daily responsibilities," NMI says. Consumers are using a variety of sources such as supplements (59%), food (51%) and beverages (30%) to prevent a lack of energy, the firm reports. "As just one manifestation of this energy trend, opportunity exists for manufacturers who can deliver effective products and messages on the stable energy benefits of low-glycemic foods and beverages," NMI says, noting that low-glycemic products "showed impressive growth with 42% of consumers indicating usage, versus 22% in 2004." Energy and vitality was No. 3 in NMI's annual "Top Ten Health & Wellness Trends" ("1The Tan Sheet" April 10, 2006, In Brief)...

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study

Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel